Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Trans-gastric Endoscopic Lumen-apposing Metal Stents for Intra-abdominal Fluid Collections after Living Donor Liver Transplantation.

Takeishi K, Yoshizumi T, Ikegami T, Itoh S, Harada N, Fujimori N, Ohno T, Mori M.

Liver Transpl. 2019 Dec 23. doi: 10.1002/lt.25707. [Epub ahead of print]

PMID:
31869521
2.

Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.

Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T.

J Gastroenterol Hepatol. 2019 Nov 14. doi: 10.1111/jgh.14929. [Epub ahead of print]

PMID:
31724755
3.

Endoscopic removal of a lumen-apposing metal stent that migrated into the walled-off necrosis during the first drainage procedure.

Fujimori N, Minoda Y, Murakami M, Suehiro Y, Oono T, Ihara E, Ogawa Y.

Endoscopy. 2019 Sep 9. doi: 10.1055/a-0992-8900. [Epub ahead of print] No abstract available.

PMID:
31499535
4.

Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.

Fujita N, Nishie A, Asayama Y, Ishigami K, Fujimori N, Ito T, Honda H.

Acta Radiol. 2019 Sep 2:284185119872687. doi: 10.1177/0284185119872687. [Epub ahead of print] No abstract available.

PMID:
31475847
5.

Forward-viewing endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions.

Minoda Y, Fujimori N, Ihara E.

Dig Endosc. 2019 Nov;31(6):e103-e104. doi: 10.1111/den.13476. Epub 2019 Aug 1. No abstract available.

PMID:
31368200
6.

Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus.

Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E.

Clin J Gastroenterol. 2020 Feb;13(1):83-89. doi: 10.1007/s12328-019-01018-1. Epub 2019 Jul 10.

PMID:
31292843
7.

CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.

Miki M, Oono T, Fujimori N, Takaoka T, Kawabe K, Miyasaka Y, Ohtsuka T, Saito D, Nakamura M, Ohkawa Y, Oda Y, Suyama M, Ito T, Ogawa Y.

Cancer Med. 2019 Jul;8(8):3748-3760. doi: 10.1002/cam4.2232. Epub 2019 May 25.

8.

Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis.

Joshita S, Umemura T, Yamashita Y, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E.

Hepatol Res. 2019 Oct;49(10):1236-1243. doi: 10.1111/hepr.13361. Epub 2019 Jun 14.

PMID:
31077509
9.

Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.

Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D, Fujimori N, Ohno T, Oda Y, Nakamura M.

Ann Surg Oncol. 2019 May;26(5):1528-1534. doi: 10.1245/s10434-019-07309-8. Epub 2019 Mar 13.

PMID:
30868514
10.

[Fulminant type 1 diabetes mellitus following acute pancreatitis and hypoglycemia with sequential imaging of the pancreas using computed tomography: a case report].

Miyagahara T, Fujimori N, Oono T, Okamoto M, Sato N, Sonoda N, Kohashi K, Ishigami K, Ogawa Y.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(2):161-167. doi: 10.11405/nisshoshi.116.161. Japanese.

PMID:
30745554
11.

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study.

Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E.

Medicine (Baltimore). 2019 Feb;98(6):e14475. doi: 10.1097/MD.0000000000014475.

12.

Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.

Miki M, Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.

J Dig Dis. 2019 Mar;20(3):152-158. doi: 10.1111/1751-2980.12708.

PMID:
30701685
13.

Current status, problems, and perspectives of non-alcoholic fatty liver disease research.

Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E.

World J Gastroenterol. 2019 Jan 14;25(2):163-177. doi: 10.3748/wjg.v25.i2.163. Review.

14.

Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.

Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E.

Cytokine. 2018 Nov;111:357-363. doi: 10.1016/j.cyto.2018.10.004. Epub 2018 Oct 5.

PMID:
30296712
15.

Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.

Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E.

J Viral Hepat. 2018 Dec;25(12):1462-1471. doi: 10.1111/jvh.12973. Epub 2018 Aug 30.

PMID:
30044517
16.

Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients.

Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E.

Hepatol Res. 2018 Dec;48(13):1092-1098. doi: 10.1111/hepr.13223. Epub 2018 Jul 27.

PMID:
29935004
17.

Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy.

Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.

Biomed Res Int. 2018 May 17;2018:8719397. doi: 10.1155/2018/8719397. eCollection 2018.

18.

Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.

Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E.

Sci Rep. 2018 May 25;8(1):8159. doi: 10.1038/s41598-018-26531-0.

19.

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.

Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M.

Oncotarget. 2018 Apr 13;9(28):19650-19661. doi: 10.18632/oncotarget.24752. eCollection 2018 Apr 13.

20.

Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.

Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.

Pancreatology. 2018 Apr 30. pii: S1424-3903(18)30079-6. doi: 10.1016/j.pan.2018.04.012. [Epub ahead of print]

PMID:
29730245
21.

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.

Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E.

World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.

22.

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.

Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E.

PLoS One. 2018 Apr 4;13(4):e0195632. doi: 10.1371/journal.pone.0195632. eCollection 2018.

23.

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.

Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E.

World J Gastroenterol. 2018 Mar 21;24(11):1239-1249. doi: 10.3748/wjg.v24.i11.1239.

24.

A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.

Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E.

J Infect Chemother. 2018 May;24(5):393-397. doi: 10.1016/j.jiac.2017.11.006. Epub 2017 Dec 18. Review.

PMID:
29249641
25.

Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.

Lee L, Ito T, Igarashi H, Miki M, Fujimori N, Kawabe K, Jensen RT, Ogawa Y.

Cancer Chemother Pharmacol. 2018 Jan;81(1):163-169. doi: 10.1007/s00280-017-3482-7. Epub 2017 Nov 21.

PMID:
29164297
26.

Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection.

Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E.

Hepatol Res. 2018 Mar;48(4):275-285. doi: 10.1111/hepr.12997. Epub 2017 Dec 4.

PMID:
29114991
27.

Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.

Tanaka N, Takahashi S, Hu X, Lu Y, Fujimori N, Golla S, Fang ZZ, Aoyama T, Krausz KW, Gonzalez FJ.

Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3170-3182. doi: 10.1016/j.bbadis.2017.08.017. Epub 2017 Aug 24.

28.

High Constitutive Overexpression of Glycosyl Hydrolase Family 17 Delays Floral Transition by Enhancing FLC Expression in Transgenic Arabidopsis.

Enoki S, Fujimori N, Yamaguchi C, Hattori T, Suzuki S.

Plants (Basel). 2017 Jul 25;6(3). pii: E31. doi: 10.3390/plants6030031.

29.

Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.

Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E.

Clin J Gastroenterol. 2017 Oct;10(5):452-458. doi: 10.1007/s12328-017-0760-1. Epub 2017 Jul 4.

PMID:
28676994
30.

Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C.

Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Igarashi K, Tanaka E.

Sci Rep. 2017 Apr 20;7:46705. doi: 10.1038/srep46705.

31.

Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.

Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.

Pancreas. 2017 Apr;46(4):476-481. doi: 10.1097/MPA.0000000000000772.

PMID:
28230660
32.

Association between endotoxemia and histological features of nonalcoholic fatty liver disease.

Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E.

World J Gastroenterol. 2017 Jan 28;23(4):712-722. doi: 10.3748/wjg.v23.i4.712.

33.

Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.

Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M.

Liver Int. 2017 Jun;37(6):897-905. doi: 10.1111/liv.13316. Epub 2016 Dec 6.

PMID:
27860118
34.

Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.

Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E.

Springerplus. 2016 Jul 7;5(1):998. doi: 10.1186/s40064-016-2708-1. eCollection 2016.

35.

Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.

Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E.

Hepatol Res. 2017 Apr;47(5):405-418. doi: 10.1111/hepr.12762. Epub 2016 Jul 24.

PMID:
27288988
36.

Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.

Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E.

Hepatol Res. 2016 Sep;46(10):1019-27. doi: 10.1111/hepr.12649. Epub 2016 Mar 15.

PMID:
27183219
37.

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E.

Hepatol Res. 2017 Feb;47(2):226-233. doi: 10.1111/hepr.12712. Epub 2016 Apr 22.

PMID:
27029022
38.

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.

Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E.

BBA Clin. 2015 Feb 19;3:168-74. doi: 10.1016/j.bbacli.2015.02.001. eCollection 2015 Jun.

39.

Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.

Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E.

Hepatol Res. 2016 Aug;46(9):884-9. doi: 10.1111/hepr.12631. Epub 2016 Jan 11.

PMID:
26662612
40.

Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.

Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H, Kawabe K, Igarashi H, Nakamura K, Oda Y, Ito T.

Scand J Gastroenterol. 2016;51(2):245-52. doi: 10.3109/00365521.2015.1083050. Epub 2015 Sep 11.

PMID:
26513346
41.

[Gemcitabine in Combination with Cisplatin in Patients with Unresectable Advanced or Recurrent Biliary Tract Cancer--A Multicenter Prospective Observational Study in Fukuoka].

Yamashita Y, Sirabe K, Kawabe K, Fujimori N, Hisano T, Okabe Y, Akiyama T, Ueki T, Horiuchi H, Yamaguchi H, Ito T, Suga H, Funakosi A.

Gan To Kagaku Ryoho. 2015 Oct;42(10):1185-9. Japanese.

PMID:
26489546
42.

Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.

Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.

Jpn J Clin Oncol. 2015 Dec;45(12):1131-8. doi: 10.1093/jjco/hyv143. Epub 2015 Sep 15.

43.

Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.

Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M.

PLoS One. 2015 Jun 25;10(6):e0131658. doi: 10.1371/journal.pone.0131658. eCollection 2015.

44.

Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.

Kohjima M, Yoshimoto T, Enjoji M, Fukushima N, Fukuizumi K, Nakamura T, Kurokawa M, Fujimori N, Sasaki Y, Shimonaka Y, Murata Y, Koyama S, Kawabe K, Haraguchi K, Sumida Y, Harada N, Kato M, Kotoh K, Nakamuta M.

World J Gastroenterol. 2015 Mar 21;21(11):3291-9. doi: 10.3748/wjg.v21.i11.3291.

45.

Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors.

Hijioka M, Ito T, Igarashi H, Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.

Cancer Sci. 2014 Nov;105(11):1464-71. doi: 10.1111/cas.12533. Epub 2014 Oct 18.

46.

Plant DNA-damage repair/toleration 100 protein repairs UV-B-induced DNA damage.

Fujimori N, Suzuki N, Nakajima Y, Suzuki S.

DNA Repair (Amst). 2014 Sep;21:171-6. doi: 10.1016/j.dnarep.2014.05.009. Epub 2014 Jun 17.

PMID:
24951183
47.

A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.

Niina Y, Ito T, Oono T, Nakamura T, Fujimori N, Igarashi H, Sakai Y, Takayanagi R.

Pancreatology. 2014 May-Jun;14(3):201-10. doi: 10.1016/j.pan.2014.02.009. Epub 2014 Mar 15.

PMID:
24854616
48.

Endoscopic approach through the minor papilla for the management of pancreatic diseases.

Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.

World J Gastrointest Endosc. 2013 Mar 16;5(3):81-8. doi: 10.4253/wjge.v5.i3.81.

49.

Retroperitoneal fibrosis associated with immunoglobulin G4-related disease.

Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R.

World J Gastroenterol. 2013 Jan 7;19(1):35-41. doi: 10.3748/wjg.v19.i1.35. Review.

50.

ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.

Uchida M, Ito T, Nakamura T, Igarashi H, Oono T, Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.

Lab Invest. 2013 Jan;93(1):41-53. doi: 10.1038/labinvest.2012.156. Epub 2012 Nov 12.

Supplemental Content

Loading ...
Support Center